FFX: System, Gastrointestinal Motility (Electrical)
What it covers
A gastrointestinal motility monitoring system is a device used to measure peristalic activity or pressure in the stomach or esophagus by means of a probe with transducers that is introduced through the mouth into the gastrointestinal tract. The device may include signal conditioning, amplifying, and recording equipment. This generic type of device includes the esophageal motility monitor and tube, the gastrointestinal motility (electrical) system, and certain accessories, such as a pressure transducer, amplifier, and external recorder.
The identification in 21 CFR 876.1725, gastrointestinal motility monitoring system. FDA gives FFX no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262621 | Rapid Barostat Bag (RBB) Pump and Catheter System | Mui Scientific, Inc. | Sep 30, 2026 | Special |
| K252605 | mcompass Anorectal Balloon Expulsion Catheter (RMD-003-001) | Medspira, LLC | Dec 5, 2025 | Traditional |
| K240007 | Solar Compact (G4-1) | Laborie Medical Technologies, Corp. | May 6, 2024 | Traditional |
| K231861 | EndoflipTM 300 System | Covidien, LLC | Jul 21, 2023 | Special |
| K223705 | EndoflipTM 300 | Covidien, LLC | Apr 14, 2023 | Traditional |
| K222000 | Transit-Pellets | Medifactia AB | Jan 18, 2023 | Traditional |
| K201106 | IntraMarX 3D Radiopaque Marker | Anx Robotica Corp | May 21, 2020 | Special |
| K191087 | IntraMarX Radiopaque Markers | Anx Robotica Corp | Dec 18, 2019 | Traditional |
| K190208 | Diversatek Healthcare High Resolution Impedance Manometry (HRiM) Probe | Diversatek Healthcare | Oct 3, 2019 | Traditional |
| K181760 | Transit-Pellets | Medifactia AB | Aug 8, 2019 | Traditional |
Clearances by year
22 FFX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 64 |
| 2025 | 1 | 109 |
| 2024 | 1 | 125 |
| 2023 | 3 | 123 |
| 2020 | 1 | 27 |
| 2019 | 4 | 240 |
| 2018 | 1 | 136 |
| 2017 | 2 | 217 |
| 2016 | 3 | 145 |
| 2013 | 1 | 107 |
| 2012 | 4 | 120 |
Who submits
13 applicants cleared a FFX device since 2011. 50% of the clearances went to applicants in United States, then Canada (18%), Ireland (14%) and Sweden (9%). By type: Traditional 77% and Special 23%.
| Applicant | Clearances since 2011 |
|---|---|
| Crospon, Ltd. | 5 |
| Mui Scientific | 3 |
| Anx Robotica Corp | 2 |
| Covidien, LLC | 2 |
| Medifactia AB | 2 |
| Diversatek Healthcare | 1 |
| Given Imaging , Ltd. | 1 |
| Konsyl Pharmaceuticals | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 876.1725.
Standards
21 CFR 876.1725 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent FFX clearances declared.
Ask about FFX
Questions about FFX
What is FDA product code FFX?
Product code FFX, “System, Gastrointestinal Motility (Electrical)” in FDA's classification database, is a Class II device type under 21 CFR 876.1725 (gastrointestinal motility monitoring system), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 70 clearances under FFX, 22 of them since 2011.
How many 510(k) clearances are there under FFX?
FDA’s 510(k) database listed 70 clearances under FFX as of Oct 29, 2026, 22 of them decided since 2011; the most recent decision was Sep 30, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a FFX 510(k)?
For the 2 FFX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 87 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most FFX clearances?
Since 2011: Crospon, Ltd. (5), Mui Scientific (3), Anx Robotica Corp (2), Covidien, LLC (2) and Medifactia AB (2). 13 applicants have cleared a FFX device in that time.